Home
Conditions
Myelodysplastic/Myeloproliferative Diseases

Clinical trial condition

Myelodysplastic/Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic/Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

49 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic/Myeloproliferative Diseases trial results

Completed

Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant

NCT00281814

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +63 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant

NCT00530218

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +21 more
Locations: City of Hope National Medical Center Duarte, California, United States

View Trial Details

Completed

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

NCT00006239

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00265837

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +64 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

NCT00003961

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment

NCT00066248

Conditions: Astrocytoma, Blast Crisis, Body Weight, +83 more
Locations: CCOP - Bay Area Tumor Institute Oakland, California, United States

Children's Hospital & Research Center Oakland Oakland, California, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Florida Shands Cancer Center Gainesville, Florida, United States

View all 43 locations

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00054327

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +51 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004899

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Myelodysplastic/Myeloproliferative Diseases

Myelodysplastic/Myeloproliferative Diseases trial results

Related conditions